glp 1 gip triple agonist retatrutide mechanism glp-1 glucagon Treatment with retatrutide, an agonist to GLP-1 Demonstrated metabolic effects of GIP,

Ann Family Med 10(1):1522 Rubin RR (2005) Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus

Statements Data availability statement The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author

J Biomed Sci (2017) 24(1):76

Lisdexamfetamine (Vyvanse) is the only medication specifically approved for moderate to severe BED in adults, typically used alongside psychotherapy

While both Lixisenatide and Liraglutide are well-tolerated, the former is superior at lowering weight and improving blood glucose levels [248], [249], [250], [251]